ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ: AVNR) today announced that it will release complete financial results for the three months and fiscal year ended September 30, 2007 before market open on Tuesday, December 11, 2007. Keith Katkin, President and Chief Executive Officer, Randall Kaye, M.D., Senior Vice President and Chief Medical Officer, and Martin Sturgeon, Vice President and Interim Chief Financial Officer, will host an investment community conference call that same day at 8:00 a.m. Pacific time / 11:00 a.m. Eastern time to discuss those results and answer questions.
